A new open access, online-only, multidisciplinary research journal dediated to highlighting the most important scientific advances in Parkinson’s disease research.
GRAND RAPIDS, Mich. (February 22, 2016)—A medication approved to treat various respiratory diseases and that has demonstrated neuroprotective effects in preclinical studies is the focus of a new clinical trial for Parkinson’s disease. The trial is the latest to be launched as part of the Linked Clinical Trials (LCT) initiative,… A psychological journey with Parkinson’s For me, Parkinson’s has been a strange journey which has generated some major highs and some quite extraordinary lows. Oddly, most of the lows were in my early years with the condition, even though this was a time when my symptoms were at their least… "Mummy, is Parkinson's contagious?" In her own way my daughter, Frida, had been interested in Parkinson's research since she was about five or six years old. And rightly so, as she was only four months old when I was diagnosed. "You have Parkinson's," the neurologist said, "Have a nice day."… Our second 'Rallying' Meeting took place on Wednesday 30th September during the Grand Challenges in Parkinson's Disease event in Grand Rapids, Michigan. Wednesday, September 30 10:30 am: Tom Isaacs (Co-founder and president, The Cure Parkinson’s Trust): Rallying to the Challenge II 10:45 am: Progress from Rallying to the Challenge I (series of… By Richard Windle There are not many good things associated with Parkinson’s. Sometimes it seems to be intent on destroying everything that you used to be. One thing that benefits many is meeting others with the condition often, due to the internet, from all over the world. One such person…